Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First RelapseEric L. Sievers, Matthias Theobald, Jacques J. M. van Dongen et al.|Journal of Clinical Oncology|2001Cited by 898